Clinical trial
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of…
NCT00134238 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00134238 |
|---|---|
| Title | Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. |
| Official title | Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in… |
| Acronym | RADIANCE 2 |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mixed Hyperlipidemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 755 |
| Start date | Nov 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Feb 17, 2012 |
| Countries | Canada, Czechia, Finland, France, Netherlands, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: